Future perspectives: targeting fibroblast growth factor receptor 1 to enhance the efficacy of immunotherapy by Ilya Tsimafeyeu

Get full text

Real-world outcomes of lenvatinib plus pembrolizumab in intermediate- and poor-risk metastatic renal cell carcinoma by Ilya Tsimafeyeu, Alexander Sultanbaev, Daria Dubovichenko, Makhabbat Murzalina, Alexander Volkov, Rashida Orlova, Igor Utyashev, Georgy Malina, Mark Gluzman

Get full text

Prevalence of erectile dysfunction and its association with age in patients with metastatic renal cell carcinoma: results from a prospective multicenter study by Yulia Tishova, Ruslan Zukov, Lev Demidov, Pavel Borisov, Vladimir Kuznetsov, Valentina Leonenko, Anastasia Tarasova, Kristina Zakurdaeva, Ilya Tsimafeyeu

Get full text

Maintenance Therapy With Avelumab for Patients With Metastatic Urothelial Carcinoma: A Real‐World, Ambispective RAVE‐Bladder Study by Ilya Tsimafeyeu, Yana Gridneva, Alexander Sultanbaev, Yulia Anzhiganova, Mark Gluzman, Anastasia Mochalova, Alexey Shkurat, Edgar Israelyan, Elvira Parsadanova, Yulia Murzina, Aleksei Ivanov, Alexey Kalpinskiy, Olesia Stativko, Vladislav Petkau, Elena Karabina, Artyom Kеln, Natalya Tovbik, Sufia Safina, Maria Turganova, Evgeny Kopyltsov, Varvara Bragina, Olga Novikova, Andrei Lebedinets, Vladislav Vodolazskiy, Alexey Rumyantsev, Ruslan Zukov, Ilya Pokataev, Rashida Orlova, Maria Volkova

Get full text